v3.0.7
Please consider this website is continuously evolving and still under development
to harmonize automatic data extraction and integrate manual data annotation.
Column | Value |
---|---|
Trial registration number | NCT04886362 |
Full text link
Last imported at : May 16, 2021, 12:32 a.m. Source : ClinicalTrials.gov |
|
First author
Last imported at : May 16, 2021, 12:32 a.m. Source : ClinicalTrials.gov |
|
Contact
Last imported at : May 16, 2021, 12:32 a.m. Source : ClinicalTrials.gov |
ceivercol@suramericana.com.co |
Registration date
Last imported at : May 16, 2021, 12:32 a.m. Source : ClinicalTrials.gov |
2021-05-14 |
Recruitment status
Last imported at : May 5, 2023, 8 p.m. Source : ClinicalTrials.gov |
Unknown |
Study design
Last imported at : May 16, 2021, 12:32 a.m. Source : ClinicalTrials.gov |
RCT |
Allocation
Last imported at : May 16, 2021, 12:32 a.m. Source : ClinicalTrials.gov |
Randomized |
Design
Last imported at : May 16, 2021, 12:32 a.m. Source : ClinicalTrials.gov |
Parallel |
Masking
Last imported at : May 16, 2021, 12:32 a.m. Source : ClinicalTrials.gov |
Blind label |
Center
Last imported at : May 16, 2021, 12:32 a.m. Source : ClinicalTrials.gov |
unclear |
Study aim
Last imported at : May 16, 2021, 12:32 a.m. Source : ClinicalTrials.gov |
Treatment |
Inclusion criteria
Last imported at : May 16, 2021, 12:32 a.m. Source : ClinicalTrials.gov |
inclusion criteria: - age equal to or greater than 18 years. - patients with positive antigen test or rt-pcr for sars-cov-2. - patients with less than 7 days from symptoms onset. - patients with indication for outpatient management. - patients with mild disease according to the official guide "pneumonia diagnosis and treatment scheme for novel coronavirus infection (trial version 8)": subjects with mild symptoms, with or without radiological signs of pneumonia, with oxygen saturation>90% . - able to provided consent to participate. |
Exclusion criteria
Last imported at : May 16, 2021, 12:32 a.m. Source : ClinicalTrials.gov |
- patients who at the time of admission require hospitalization and / or supplemental oxygen. - known history of allergy to ivermectin. - known medical history of liver disease. - belong to another clinical trial evaluating the efficacy of an investigational drug against covid-19. - the following comorbidities: - immunosuppression or hiv. - acute or chronic kidney failure. - current neoplasia. - currently use of warfarin, erdafitinib, or quinidine. - have received vaccination for sars-cov-2. - ivermectin consumption prior to inclusion in the research protocol. - the patient does not accept the conditions of home care and monitoring. - the patient desists from participating in the study. - women in pregnancy or breastfeeding. |
Number of arms
Last imported at : May 16, 2021, 12:32 a.m. Source : ClinicalTrials.gov |
2 |
Funding
Last imported at : May 16, 2021, 12:32 a.m. Source : ClinicalTrials.gov |
Ayudas Diagnosticas Sura S.A.S |
Inclusion age min
Last imported at : May 16, 2021, 12:32 a.m. Source : ClinicalTrials.gov |
18 |
Inclusion age max
Last imported at : May 16, 2021, 12:32 a.m. Source : ClinicalTrials.gov |
100 |
Countries
Last imported at : May 16, 2021, 12:32 a.m. Source : ClinicalTrials.gov |
None |
Type of patients
Last imported at : May 16, 2021, 12:32 a.m. Source : ClinicalTrials.gov |
Mild disease at enrollment |
Severity scale
Last imported at : May 16, 2021, 12:32 a.m. Source : ClinicalTrials.gov |
1: Mild disease at enrollment |
Total sample size
Last imported at : May 16, 2021, 12:32 a.m. Source : ClinicalTrials.gov |
966 |
primary outcome
Last imported at : May 16, 2021, 12:32 a.m. Source : ClinicalTrials.gov |
Composite Outcome |
Notes
Last imported at : May 16, 2021, 12:32 a.m. Source : ClinicalTrials.gov |
None |
Phase
Last imported at : May 16, 2021, 12:32 a.m. Source : ClinicalTrials.gov |
Phase 2/Phase 3 |
Arms
Last imported at : May 16, 2021, 12:32 a.m. Source : ClinicalTrials.gov |
[{"arm_notes": "", "treatment_id": 693, "treatment_name": "Ivermectin", "treatment_type": "Antiparasitics", "pharmacological_treatment": "Pharmacological treatment"}, {"arm_notes": "", "treatment_id": 2187, "treatment_name": "Placebo", "treatment_type": "Placebo", "pharmacological_treatment": "Placebo"}] |